Try our Advanced Search for more refined results
Rifaximin
- February 09, 2024 Sandoz Patent For IBS-Treating Antibiotic Fails On Appeal
- August 18, 2023 Teva Wants In On FDA Suit To Defend Dibs On Xifaxan Generic
- April 21, 2023 Indian Pharma Co. Can't Revive Claim Over Xifaxan Royalties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login